Medical Affairs Professional Society

Enhancing Collaboration: Streamlining Access to Scientific Literature for Medical Affairs Teams
2025-06-24 10:30 - 11:30 (America/New_York)
Join a conversation with three medical affairs industry experts about the increasing importance of timely access to high-quality scientific content. This moderated panel discussion will focus on best practices for medical affairs teams when acquiring, managing, and disseminating scientific articles and other content to internal stakeholders, as well as sharing content externally in ways that are copyright compliant.

Participants will explore strategies for ensuring timely access to high-quality, relevant scientific literature that’s procured and distributed in ways that promote copyright. Participants will also discuss utilizing digital tools to facilitate literature surveillance, streamline content distribution, and foster effective communication between teams. Emphasis will be placed on how to support decision-making and enhance cross-functional collaboration, particularly from the perspective of medical information and medical excellence.

Attendees will gain insights into overcoming challenges related to content curation and the alignment of scientific information with organizational needs. After participating in this session, attendees should be able to:

Identify strategies to reduce copyright risk when procuring and sharing content

Understand best practices for searching for and acquiring literature, as well as sharing content externally in a copyright compliant manner

Possess insight into how other medical affairs teams organize and manage their documents and citations

State common challenges when sharing scientific content with stakeholders and gain insight into how other organizations overcome these challenges today

Learning Objectives

After participating in this session, attendees should be able to:

Identify strategies to reduce copyright risk when procuring and sharing content.

Understand best practices for searching for and acquiring literature.

Gain insight into how other medical affairs teams organize and manage their documents and citations.

Recognize common challenges when sharing scientific content with stakeholders and understand how other organizations overcome these challenges.

Register

Moderator:

Jackie Fucile

Product Solutions Manager

CCC

Speaker:

Cassie Singleton

Director, Medical Information

Becton Dickinson (BD)

Speaker:

Sarah Guadagno, Ph.D

Founder/Principal

8X Life Science Communications

MAPS Northeast Chapter Event - Career Progression and Development Discussion
2025-06-24 15:30 - 18:00 (America/New_York)
Join MAPS Chapter Leads and experienced Medical Affairs professionals for a discussion on career paths and development opportunities in Medical Affairs and the MSL field. Explore available resources and support for career growth.

The panelist will outline the skills companies need for current and future Medical Affairs challenges. Participants will learn about available resources through MAPS, other networks, and how they can leverage their own network.

FREE for MAPS Members

$50 USD for Non-Members (Non-members may apply the registration fee to their first year of individual membership if an application is submitted with 30 days after the event).

Register

Thank you to our Sponsor:

Venue:

Cactus Life Sciences – Stockton Conference Room-1st Floor

214 Carnegie Center, Suite 102

Princeton, New Jersey 08540

Agenda:

3:30 PM: Doors Open

4:00 – 5:00: Panel Discussion and Q&A –

Discussion Moderator:

Renu Juneja, PhD, MAPS Northeast/Mid-Atlantic Chapter Lead

Panelist:

Fatima Ahmad, PharmD

Hahn-Ey Lee, MD, PhD, MBA

Devi Mukhrjee, PhD

Elvira D’souza, Cactus

5:00– 6:00: Closing Remarks & Networking (Refreshments and lite snacks provided)

Moderator:

Renu Juneja, PhD

President, ADPAL, LLC

MAPS Northeast/Mid-Atlantic Chapter Lead

Panelist:

Fatima Ahmad, PharmD

US Medical Affairs Team Lead for Rare Endocrine and Rare Renal Disorders

Novo Nordisk

Panelist:

Hahn-Ey Lee, MD, PhD, MBA

International Medical Lead – Vaccines and Antivirals & Anti-infectives

Pfizer

Panelist:

Elvira Dsouza

President

Cactus Communications

Medical Affairs' Data Dilemma and The Path To Influence
2025-07-18 10:00 - 11:00 (America/New_York)
In a field where the essence of your work is rooted in scientific discourse rather than direct sales, showcasing your team’s value to your organization and stakeholders is a nuanced challenge. How do you establish Medical Affairs as a strategic pillar? It requires more than routine reports; it demands a comprehensive understanding of stakeholder needs and a clear articulation of long-term impact—a task easier said than done.

Learning Objectives

Data Prioritization and Storytelling: Learn to distill and prioritize data to craft compelling narratives that highlight the true impact of Medical Affairs. Discover the power of asking critical “whys” to uncover the significance of your data.

Creating Meaningful Benchmarks: Understand how to establish appropriate benchmarks in a field where conventional measures don’t always exist, guiding you to effectively demonstrate your contributions.

Demonstrating Patient Impact: Develop strategies to showcase your value and influence on patient outcomes through scientific exchange and research, innovating beyond traditional benchmarks and metrics.

Fostering Collaborative Partnerships: Explore the importance of collaboration in advancing unbranded disease education and new research initiatives, inspired by successful models that are driving innovation within the industry.

Register

Speakers:

Moderator

Ujwal Pyati

Chief Medical Officer

Real Chemistry

Speaker:

Briana Belford

Practice Leader, Integrated Intelligence

Real Chemistry

Speaker:

Ann Wheeler

VP, North America Medical Affairs

Indivior

The Future of Research Visibility: Beyond Traditional Metrics
2025-07-25 10:00 - 11:00 (America/New_York)
Unlock the full potential of your scientific content strategy by exploring how Medical Affairs teams are beginning to think beyond traditional citations and toward more meaningful ways to measure the impact of their scientific content.

In this session, a panel of experts will share their current experiences, challenges, and perspectives on tracking and interpreting the broader impact of scientific content.

While panelists may monitor content using different metrics, the discussion will explore what’s potentially useful and where the real opportunities lie. The conversation will begin by examining how scientific communications are evolving in a fast-moving, multi-channel environment. It will then consider how to track supplementary content and what the benefits of this might be.

The panel will also reflect on the kinds of metrics that could offer value beyond citations, such as indicators of engagement, visibility, and influence. These ideas will be grounded in practical relevance for Medical Affairs strategy, helping attendees think about how insights might be applied in real-world planning.

The session will close with a look ahead to what the future may hold for metrics innovation and impact measurement.

Learning Objectives:

– Consider how emerging metrics and tools might support Medical Affairs strategy and planning in the future.

– Gain insight into how different organizations are approaching impact measurement, recognizing a range of experiences and stages in adoption.

– Identify opportunities and challenges in tracking metrics beyond traditional citations, including indicators of engagement, attention, and influence.

– Explore the potential role of tracking publication extenders and their engagement across different channels.

Register

Speakers:

Moderator:

Natalie Jonk

Marketing segment Lead

Digital Science

Speaker:

Shehla Sheikh

Head of Medical communication & Publications

Kyowa Kirin

Speaker:

Kim Della Penna

Scientific Communications Director, Lymphoma/Myeloid/Multiple Myeloma

Johnson & Johnson

Speaker:

Myriam Cherif

Founder, Formerly Regional Medical Director

GSK

Speaker:

Carlos Areia

Senior Data Scientist

Digital Science

Natural History Studies: Selecting the Right Delivery Method
2025-08-22 10:00 - 11:00 (America/New_York)
The rise in rare diseases and personalized medicine has heightened the need to understand natural history and treatment pathways for unique patient populations.

Join this session to:

Review the range of delivery options

Take a deep dive into innovative approaches to consider: AI-assisted chart review, and industry/advocacy partnerships

Learning Objectives

Understand the importance of natural history studies in rare diseases and personalized medicine.

Explore various delivery methods for conducting natural history studies.

Evaluate innovative approaches, including AI-assisted chart review and industry/advocacy partnerships.

Identify key considerations for selecting the most effective delivery method based on study goals and patient population.

Register

Speakers:

Moderator

Barbara Arone

Vice President, Medical Affairs, Real World Solutions

IQVIA

Speaker:

Angela Kennedy

Senior Director, Provider and Patient Association

IQVIA

Speaker:

Stuart Turner

TA Head, General Medicines

Global RWE & Outcomes

A Rapidly Changing Regulatory Landscape: What Medical Affairs Leaders Should Know
2025-09-12 10:00 - 11:00 (America/New_York)
Recent shifts in U.S. health policy—from revised vaccine recommendations and NIH budget cuts to proposed bans on direct-to-consumer pharma advertising—are redefining the regulatory environment in which Medical Affairs operates. As the pace of change accelerates, Medical Affairs professionals must be proactive in understanding how emerging legislation, transparency expectations, and cost-containment strategies may impact their work.

This session brings together seasoned experts and leaders in Medical and Regulatory Affairs to explore the implications of a rapidly evolving policy landscape. Topics will include real-world examples of recent or proposed changes and practical steps Medical Affairs leaders can take to ensure compliance, maintain public trust, and remain agile in an uncertain environment.

Learning Objectives

Recognize how recent and proposed healthcare policy changes may impact Medical Affairs operations, strategy, and compliance expectations.

Understand the increasing emphasis on transparency, conflict-of-interest management, and ethical decision-making in a changing regulatory climate.

Identify proactive steps Medical Affairs leaders can take to align cross-functional teams and ensure preparedness in the face of regulatory shifts.

Explore how automation, digital tools, and audit-ready systems can support compliance, adaptability, and strategic decision-making.

Register

Speakers:

Moderator:

Alex Reinthal

Vice President of Product,

BP Logix

Speaker:

Michelle Chernock

Founder

Leaders in Medical Affairs

Speaker:

Jethro Ekuta

Chief Regulatory & Safety Officer

Ascendis

Speaker:

Robert Kaper

Former VP of Global Medical Affairs

Otsuka

Operationalizing Medical Strategy: A Success Story in Demonstrating Value and Impact
2025-09-19 10:00 - 11:00 (America/New_York)
Medical Affairs organizations are increasingly challenged to demonstrate their value through aligned, strategic execution that drives meaningful clinical impact. This webinar highlights how one organization successfully applied the MedImpact Model™ to achieve clarity of purpose, functional alignment, and measurable behavior change in the field.

The session will walk attendees through how the three pillars of the MedImpact Model™ —Impact Story, Contributions, and Execution—were used to translate high-level strategy into tangible action. Whether you use the MedImpact Model™ or your organization’s own framework, participants will gain practical insights in using a proven framework to empower cross-functional teams and field medical professionals to elevate their role in enabling informed therapeutic decisions and advancing patient care.

Learning Objectives

Understand how a proven framework like the MedImpact Model™ (Impact Story, Contributions, and Execution) was successfully used by an organization to drive aligned strategy and clinical behavior change.

Recognize how tactical execution can be elevated through structured planning, team alignment, and targeted coaching within a Medical Affairs organization.

Apply key lessons and practical insights to operationalizing a medical impact framework within their own teams and organizations.

Register

Speakers:

Moderator:

Linda Traylor

PhD, VP, Head of Global Medical Excellence

Acceleration

Speaker:

Joseph Giuliano

Managing Director,

Rare Medical Affairs

Speaker:

Matt Nelson

Head of US Medical Affairs,

Amicus Therapeutics

MAPA-MAPS Australasia Medical Affairs Summit 2025: Sydney
2025-09-24 00:00 - 2025-09-25 23:59 (Australia/Sydney)
Save the date!! Join us in Sydney September 24-25, 2025.

AI and the HCP Experience: Implications for Medical Affairs
2025-10-10 10:00 - 11:00 (America/New_York)
Artificial Intelligence is already reshaping how healthcare is delivered and how Medical Affairs operates. In this interactive webinar, the panel will share data from healthcare decision makers about the use of AI in health systems and discuss the impact on how Medical Affairs engages with healthcare providers and executes educational programming.

Participants will gain a deeper understanding of how AI is influencing medical decision-making and care coordination and how this will impact medical education and evidence generation. Attendees will leave equipped with actionable strategies to adapt, lead, and innovate in an AI-driven healthcare ecosystem.

Learning Objectives

Recognize how AI is currently being used by health systems and healthcare professionals in clinical practice.

Evaluate the implications of AI adoption on Medical Affairs functions, such as scientific communications, evidence generation, and stakeholder engagement.

Identify key challenges and opportunities in integrating AI into Medical Affairs workflows, including data quality, insight generation, and cross-functional collaboration.

Register

Speakers:

Moderator:

Jason McDonough

PhD, CMPP, SVP, Medical Strategy

Precision AQ

Speaker:

Sam Vaudrey

Sr. Director, Innovation & Technology

Precision AQ

Speaker:

Greg Gregory

PhD, EVP, Partner

Precision AQ

Speaker:

Adam Rodman, MD, MPH, FACP

Hospitalist, Beth Israel Deaconess Medical Center

Assistant Professor, Harvard Medical School

Director of AI Programs, Shapiro Center for Research and Education, BIDMC

Co-director, iMED Initiative at BIDMC

Thriving in Times of Transformation: Effective Leadership Practices for Supporting Teams in the Rapidly Evolving Landscape of Medical Affairs: Part 1 of 3: Five Elements of Emotional Intelligence
2025-10-22 10:00 - 11:00 (America/New_York)
In today’s rapidly evolving Medical Affairs landscape, technical expertise alone is no longer enough. To truly thrive in times of transformation, leaders must cultivate emotional intelligence—the foundation of effective leadership.

Join us for Part 1 of our 3-part, interactive 60-minute webinar series designed specifically for members of the Medical Affairs Professional Society (MAPS) who are eager to elevate their leadership and management capabilities. This session will explore the five elements of emotional intelligence—self-awareness, self-regulation, motivation, empathy, and social skills—and how they can be harnessed to build resilient, high-performing Medical Affairs teams.

Through real-world case studies, peer insights, and guided reflection, you’ll learn how emotionally intelligent leadership can:

Strengthen team cohesion and trust

Improve communication and collaboration

Enhance decision-making under pressure

Foster a culture of empathy and accountability

Register

Speakers:

Co-Moderator

Matthew John Rice

Learning Architect Director, Center for Scientific Exchange Excellence

Merck & Co., Inc.

Co-Moderator:

Deborah Braccia, PhD, MPA

Founder & Principal,

DVB Consulting

Medical Affairs Technology and Innovation Symposium 2025
2025-10-23 12:00 - 18:00 (America/New_York)
Join us for this highly interactive session featuring two expert-led panel discussions and a collaborative small-group workshop. Hear firsthand how Medical Affairs leaders are harnessing AI to transform insights, evidence, and communication—and what capabilities, structures, and strategies made those efforts successful. Then, dive into a facilitated workshop to identify how your team can begin or advance your AI journey.

In this event attendees:

• Collaborate with peers and panelists to draft your own roadmap for implementing AI, including identifying value opportunities, capability gaps, and approaches for measuring success.

• Learn how Medical Affairs teams launched successful AI initiatives in insights, evidence generation, and scientific communication and what business drivers and lessons shaped the outcomes.

• Understand the cross-functional, technical, and organizational capabilities needed to scale and sustain AI solutions in Medical Affairs.

Location:

Convene One Boston Place201 Washington StBoston, Massachusetts 02108United States

Event supported by:

Registries 101: A Medical Affairs' Value Primer
2025-10-29 10:00 - 11:00 (America/New_York)
Registries are often mentioned but much less frequently implemented. As such, many Medical Affairs professionals have not had the opportunity to put “hand on” from either a conceptual or technical standpoint. In this 60-minute webinar, a cross-functional group of experts will present the basics of why, when and how to make the most of a registry as we look to assess and address care gaps. A range of perspectives from RWE expert to HQ medical director to field medical director will be presented and examples of patient, product and disease state registries will be considered.

Objectives:

1. Describe the value of registry data in evidence generation

2. Gain insight into the purpose, design and operationalization of registries

3. Articulate the role of Medical Affairs in the design and conduct of registries

4. Appreciate the challenges and opportunities when analyzing registry data

Register

Speakers:

Moderator

Diana Morgenstern

MD, FACP, Head, RWE and Outcomes Research

Viatris

Speaker:

Angela Williams

VP, Global Head HEOR

Kyowa Kirin

Speaker:

PhD, Vice President, Medical Affairs Strategy

ImmunityBio

Updates to Insights Standards and Guidance: Evolving Best Practices
2025-10-30 10:00 - 11:00 (America/New_York)
Join us to review what’s new over the past few years. Topics will include the increasing importance of commercial collaboration, strategic frameworks, incorporation of AI, multi-modal data and impact metrics. Bring your questions!

Register

Speakers:

Jo Ann Antenor – Sobi

Brant Jarrett – Mallinckrodt Pharmaceuticals

Tony Page – Within3

Pete Piliero – MAPS

Prem Sundivakkam – Pfizer

Medical Affairs In Early Stage Development? Seriously?
2025-10-31 10:00 - 11:00 (America/New_York)
According to the OECD, the aging population is projected to increase global healthcare spending by many trillions of dollars in the coming decades.

Once the notorious killer, cardiovascular-related mortality has decreased over time—leading to an increase in prevalence of other diseases.

Brain disorders are expected to triple in cost to $15 trillion by 2030, and cancer cases are projected to increase by 77% by 2050 (McKinsey, WHO).

Healthcare systems aim to drive costs down while increasing both lifespan and health span.

It still costs over $2 billion to develop a new therapeutic (Deloitte).

60% of launched drugs don’t hit sales forecasts, and of those that miss first-year targets, only 20% recover (ZS, Trinity, IQVIA).

The upcoming patent cliff may wipe $180 billion off revenue in 2027/2028 (FT/Evaluate).

Increasingly stringent market conditions have become the norm, with policies such as Most Favored Nation pricing, drug tariffs, and EU joint HTA.

Pharmaceutical product development is more challenging than every before. Yet, most organisations do not have Medical Affairs presence in early-stage development. Why would you? Most organisations involve Medical Affairs at Phase 3 before pivotal trial read-out. This is already late if we consider the challenges affecting drug development and chances of launch success. Involving Medical Affairs early already may increase chances of progressing programmes to filing as well as increasing chances of a successful launch and return on investment.

Join our experts who will be covering the burning platform that is early stage drug development, listen and ask them questions on their thoughts on the role of Medical Affairs in early-stage drug development.

Learning Objectives

Understand the benefits and opportunities of involving Medical Affairs in early therapeutic development stages.

Learn how a robust Medical Affairs function can shape development strategy and support launch readiness.

Define the ideal role Medical Affairs should play in early product development.

Register

Speakers:

Moderator

Rakesh Kantaria

Founder and CEO

Circuit Medical

Speaker:

Dr. Samin Saeed

VP, Early Medical Pipeline, Specialty Care

GSK

Speaker:

Jan Schadrack

VP, TA Head Neuroscience and Rare Disease; Product Development Medical

Roche

Speaker:

Paulo Fontoura

Chief Medical Officer

Xaira

Redefining Evidence Generation: Innovative AI-Enabled Approaches for a New Era of Therapies
2025-11-07 10:00 - 11:00 (America/New_York)
Medical Affairs is at the center of a shifting evidence landscape. As newly approved therapies and evolving standards of care bring urgent questions about safety, effectiveness, and utilization, traditional registries and clinical trials too often fall short—delivering answers that are delayed, incomplete, or unrepresentative.

This webinar will explore how new approaches are transforming evidence generation for registries and studies by leveraging structured and unstructured electronic health records, creating flexible, living platforms that adapt as new standards of care and questions emerge. While we will highlight an Alzheimer’s initiative as an example of innovation in a complex and evolving disease area, the approaches and lessons discussed are broadly applicable across therapeutic areas.

Attendees will gain perspective on how these methods can support Medical Affairs in building stronger evidence strategies, driving scientific exchange, and enabling better communication with payers, providers, and regulators.

Learning Objectives

Recognize why traditional observational methods often fail to meet evolving evidence needs.

Understand how AI and automation can transform real-world evidence generation by improving efficiency, inclusivity, and adaptability.

Learn from an Alzheimer’s initiative as an example of how innovative approaches can build scalable, living evidence platforms.

Identify how Medical Affairs can leverage these approaches to strengthen communication, support access, and drive evidence strategies across therapeutic areas.

Register

Speakers:

Moderator

Tiffany Hadzi

VP Client Services,

OM1

Speaker:

Carl Marci, MD

Chief Clinical Officer

OM1

Speaker:

Ann Hartry

Associate Vice President, Value, Evidence, & Outcomes, Neuroscience,

Lilly

Medical Affairs Career Progression and Development Discussion - Hosted by the MAPS - Houston Chapter
2025-11-13 18:00 - 19:00 (America/North_Dakota/Center)
Program Goals:

Highlight the skills and expertise needed to meet current and future business needs and strengthen capabilities in the Medical Affairs area. As well as enhancing the participants awareness of various pearls, tools, and resources available to them and how to obtain

Program Objectives:

Discuss career pathways and development opportunities to foster a culture of continuous learning and growth within the Medical Affairs sector and MSL field. Provide resources and support for career exploration, including:

Informational interviews

Career counseling

Networking opportunities

Informational Interviews

Unlocking Externally Sponsored Research Value
2025-11-21 10:00 - 11:00 (America/New_York)
As Biopharma and regulators’ appetite for understanding the value of medicines in the real world increases—alongside the desire to be closer to patients and providers—a new lens is being placed on Externally Sponsored Research (ESR) as a key pillar in Evidence Generation (EvGen). The ability to execute EvGen strategies through Company Sponsored Studies (CSS) alone is being stretched, resulting in many companies looking to more strategic use of ESR, including with registrational intent and for signal seeking (e.g., biomarker exploration).

Learning Objectives

Articulate the key trends affecting ESR today.

Understand how industry leaders are using ESR to support evidence generation.

Identify best-practice techniques for delivery of ESR trials.

Register

Speakers:

Moderator:

Kelli Rock-Walker

Managing Director, Medical Affairs

Syneos Health

Speaker:

Kelly Haines

Senior Director, Head, Medical Study Operations

Regeneron

Leading Medical Affairs Through Transformation: Applying Goleman’s Six Styles with Emotional Intelligence
2025-12-03 10:00 - 11:00 (America/New_York)
Ready to lead change with confidence? Part 2 of our 3-part MAPS series turns insight into action. In Part 1, we unpacked Daniel Goleman’s five elements of Emotional Intelligence (EI). Now we put EI to work.

Unlock the leadership edge top Medical Affairs teams rely on. In this fast-paced, interactive 60-minute session, you’ll see how Goleman’s six leadership styles—powered by EI—deliver real-world results: faster alignment, stronger collaboration, and measurable performance. Through practical case studies, peer exchange, and guided reflection, you’ll learn exactly when to flex authoritative vs. democratic, when affiliative trumps pacesetting, and how coaching elevates talent during transformation. Walk away with a clear playbook to lead confidently, influence cross-functional partners, and build a high-trust, high-impact culture—starting immediately.

Register

Speakers:

Co- Moderator:

Matthew John Rice

Learning Architect Director, Center for Scientific Exchange Excellence

Merck & Co., Inc.

Co-Moderator:

Deborah Braccia, PhD, MPA

Harnessing AI and Real-World Evidence to Advance Alzheimer’s Screening and Equitable Access
2025-12-05 10:00 - 11:00 (America/New_York)
The approval of new Alzheimer’s therapies has reshaped the landscape of diagnosis and care, driving measurable increases in screening, biomarker testing, and provider engagement. Yet despite this progress, meaningful disparities in access and treatment persist across patient populations.

In this educational webinar, experts will present findings from a recent joint research initiative. The session will explore how AI-driven analysis of real-world data (RWD) can illuminate trends in Alzheimer’s screening, testing, and treatment—and critically, where inequities remain. Given that emerging treatments create opportunities to improve patient care, this discussion will offer a complementary perspective on how the approval of new therapies drives information-seeking among healthcare professionals (HCPs) and creates opportunities for funding and external education.

Ultimately, targeted HCP education influences knowledge, confidence, and clinical practice—underscoring its vital role in improving equitable outcomes.

Attendees will gain practical insights into:

The impact of new therapies on real-world screening and diagnostic practices

Leveraging AI and RWE to precisely identify and quantify key disparities across race, gender, and insurance type

How HCP education and training can effectively close knowledge and practice gaps for more equitable care

Actionable approaches for Medical Affairs teams to apply these data-driven insights to their own therapeutic areas

Learning Objectives

Analyze the real-world impact of new Alzheimer’s therapies on screening and diagnostic practices using AI-driven RWE.

Identify and quantify specific disparities in Alzheimer’s access and treatment across key patient demographics (race, gender, insurance type).

Evaluate the role of targeted HCP education in addressing knowledge gaps and promoting equitable patient care.

Develop actionable strategies for applying RWE and AI approaches to illuminate inequities within their own therapeutic areas.

Register

Speakers:

Moderator:

Tabby Khan

Senior Director, Analytics

Komodo Health

Speaker:

Katie Lucero

PhD, Chief Impact Officer

Medscape

Speaker:

Rob Adamoski

Vice President, Medical Affairs

Corcept

Beyond the Buzz: Practical AI for Launch Impact
2025-12-09 10:00 - 11:00 (America/New_York)
AI is transforming how Medical Affairs teams gather, interpret, and act on insights—but many leaders are still asking: What’s hype, and what’s real in the next 12–18 months?

In this session, we’ll explore how AI is evolving to meet the practical needs of Medical Affairs and what that means for launch readiness, cross-functional collaboration, and measurable impact. Building on the latest use cases, we’ll show how AI can orchestrate insights across functions—enabling teams to anticipate needs, avoid missteps, and make confident decisions faster.

You’ll leave with actionable strategies to:

Understand where AI can deliver immediate value versus longer-term promise.

Gather and integrate data across Medical, Commercial, and Field teams to enable real-time clarity and demonstrate clinical impact.

Generate insights that directly support launch objectives and market understanding.

Align functions earlier in the process to build a unified, insight-driven approach to strategy.

Learning Objectives

Identify where AI can deliver immediate value for Medical Affairs teams versus longer-term potential.

Demonstrate how Medical Affairs can leverage AI to measure and communicate strategic impact across the product lifecycle.

Identify practical AI applications that accelerate launch readiness and enable faster, data-driven decisions.

Register

Speakers:

Moderator:

Gareth Morrell

Head of Research and Insights

Impatient Health

Speaker:

Lance Hill

CEO

Within3

Speaker:

Jason Smith

CTO, AI & Analytics

Within3

Moderator:

Speaker:

Prem Sundivakkam, PhD, MBA

Executive Lead, Global Medical Affairs, Communications and Congress I Internal Medicine, Antivirals

Pfizer

Benchmark Review: Launch Readiness and Execution
2025-12-11 12:00 - 13:00 (America/New_York)
The 2025 Medical Affairs Launch Readiness & Execution Benchmark Report reveals a pivotal moment for Medical Affairs as it rises to co-lead the next generation of product launches. Drawing on insights from 35 senior leaders across 28 global pharma, biotech, and medtech organizations, MAPS’ latest Benchmark Report uncovers how Medical is being brought earlier into planning, tasked with broader stakeholder engagement, and relied upon to shape strategy and evidence for increasingly complex therapies. Leaders highlight widening responsibilities—spanning payers, patients, and precision-defined populations—while also confronting real barriers like limited digital adoption and cross-functional friction. The report maps out the capability spine Medical teams need to strengthen to thrive under rising expectations, from launch strategy and evidence generation to field insights and expert engagement. Ultimately, it provides a blueprint for how Medical can scale its impact and drive launch excellence in an era defined by scientific complexity and rapid innovation.

Join us for a special LinkedIn Live session where industry leaders in Medical Affairs and Launch Excellence will break down the report’s findings, share real-world perspectives, and challenge the status quo. Don’t miss this chance to hear experts debate what’s coming next—and how Medical teams can prepare to lead.

Join the Event!

Speaker:

Tommaso Poggioli

Partner

BCG

Speaker:

Drew Macgregor

Vice President, Global Head of External Medical Services

Bayer

Speaker:

Arron Mungul

Founder

Apogee Life Sciences Limited

Speaker:

Liliana Alfaya

Launch Excellence Competency Team Lead

Speaker:

Korinne Jew

Senior Director, Enterprise Clinical Research & Medical Science

Medtronic

Medical Affairs Future & Festivities - A Holiday Networking Event
2025-12-11 17:00 - 21:00 (America/Chicago)
Celebrate the close of another impactful year with fellow Medical Affairs professionals from across the Midwest. Enjoy an evening of conversation, connection, and collaboration as we reflect on shared accomplishments, build new relationships, and look ahead to the new year.

Enjoy interactive poster presentations throughout the event highlighting bold ideas and transformative possibilities for Medical Affairs in 2026. This will be a valuable opportunity to exchange insights, explore forward-thinking concepts, and connect with peers committed to shaping our future.

Poster Presentation Topic: Bold ideas and transformative possibilities for Medical Affairs in 2026

Poster presentation contributors will deliver brief presentations to introduce innovative and unconventional concepts—utilizing technology, strategic approaches, and stakeholder engagement—with the potential to transform the Medical Affairs landscape by 2026.

Vote for the Most Thought-Provoking Poster! The winning poster will be featured in the MAPS eNewsletter and on social media channels in January 2026.

This event is free and open to all MAPS Members

Non-members Registration $50

Register

Location:

White Deer Run

250 W Greggs Pkwy

Vernon Hills, IL 60061

Host:

Prem Sundivakkam

Executive Lead, Global Medical Affairs, Communications and Congress

Pfizer

Host:

Nihar Baxi

Senior Director, Regulatory Affairs

Emergent BioSolutions

Patient-Centric Medical Affairs: From High-Level Strategy to Day-to-Day Impact
2025-12-12 10:00 - 11:00 (America/New_York)
Discover how embedding patient engagement from the top down can transform your Medical Affairs strategy—driving genuine patient-centricity, meaningful impact, and long-term success. Join us to learn practical insights on integrating the patient voice at every level of decision-making and how this approach can revolutionize YOUR approach to medical strategy.

John Ioannou will present how UCB has integrated the patient perspective into multiple levels of decision making, facilitating continued meaningful patient engagement throughout the various stages of drug development and launch. Sorcha Ní Dhochartaigh will discuss how early and long-term patient involvement across Medical Affairs projects can compliantly add value and increase the impact of our work. She will be joined by Mark and Karen Verrill, representatives from Maggie’s charity, to provide the clinical perspective on what ‘good’ patient engagement looks like.

Skills and knowledge gained in the webinar will be directly transferrable, allowing individuals to more effectively develop patient-centric medical strategic plans and communicate their value.

Learning Objectives:

Understand actionable methods for involving the patient voice in Medical Affairs strategy.

Communicate the value of patient engagement in high-level Medical Affairs strategy to colleagues and managers.

Implement practical tips to maximize the meaningfulness and impact of engaging patients in Medical Affairs strategy throughout the product lifecycle.

Register

Speakers:

Moderator:

Alice Wilcox

Senior Analyst

Costello Medical

Speaker:

John Ioannou

Global Medical Head of Immunology Therapeutic Area

UCB

Speaker:

Sorcha Ní Dhochartaigh

Therapy Area Lead, GI,

AstraZeneca

Speaker:

Karen Verrill

Centre Head

Maggie’s Centres

Leading Medical Affairs Through Transformation: The Five Practices of Exemplary Leadership in Action
2025-12-17 10:00 - 11:00 (America/New_York)
Ready to turn change into momentum? Part 3 of our 3-part MAPS leadership series brings Kouzes and Posner’s Five Practices to life for Medical Affairs. Building on Part 1 (Goleman’s Emotional Intelligence) and Part 2 (applying six leadership styles), this fast-paced, interactive 60-minute session shows you exactly how to:

Model the Way: Lead by example under pressure—especially when tight timelines tempt teams to cut corners on standards and integrity.

Inspire a Shared Vision: Align skeptical stakeholders behind bold, feasible goals by articulating a clear future state, connecting it to shared priorities, and outlining practical steps to get there.

Challenge the Process: Break silos and spark innovation—improving MSL–regulatory flow and learning through small wins.

Enable Others to Act: Strengthen trust, collaboration, and confidence so teams contribute powerfully to high-stakes deliverables.

Encourage the Heart: Recognize excellence and celebrate wins to sustain performance through demanding cycles.

Through realistic Medical Affairs scenarios, peer insights, and a hands-on simulation, you’ll leave with concrete practices you can apply immediately to elevate team performance, accelerate transformation, and build a resilient, high-trust culture.

Register

Speakers:

Co- Moderator:

Matthew John Rice

Learning Architect Director, Center for Scientific Exchange Excellence

Merck & Co., Inc.

Co-Moderator:

Deborah Braccia, PhD, MPA

The MAPS Year-End Networking Social
2025-12-17 17:00 - 21:00 (America/New_York)
Join us for the MAPS Year-End Networking Social – hosted by the MAPS New England Chapter

Celebrate the close of another impactful year with fellow Medical Affairs professionals from across New England. Enjoy an evening of conversation, connection, and collaboration as we reflect on shared accomplishments, build new relationships, and look ahead to the new year.

Complimentary refreshments will be provided.

This event is FREE and open to all MAPS Members

Non-member may register for a fee of $50 (Registration fees will be applied to your first year of membership if you register as a member after the event).

Register

Host:

Mary Winkels

Director, Field Medical Excellence

Madrigal Pharmaceuticals

Hosts:

Aaron Tarkinson

Sr. Director & Head of Medical Strategy

Biogen

Expanding Your Medical Affairs Impact: Strategic Engagement Beyond the Prescribing Physician
2026-01-16 10:00 - 11:00 (America/New_York)
In today’s complex healthcare landscape, patient outcomes depend on a diverse network of stakeholders far beyond the prescribing physician. Join us as we explore why traditional Medical Affairs engagement models need to evolve and examine strategies for building meaningful relationships with nurses, pharmacists, patients, advocacy groups, and other influential voices in healthcare delivery.

Whether you’re considering broadening your current engagement strategy or looking to understand the evolving Medical Affairs landscape, this session will provide valuable insights and practical guidance for multi-stakeholder engagement.

Learning Objectives

Recognize key non-prescribing stakeholder groups that influence patient outcomes in modern healthcare delivery.

Gain insights on why traditional Medical Affairs engagement models need to evolve to address today’s complex healthcare landscape.

Determine successful strategies and practical approaches for engaging diverse healthcare stakeholders based on real-world industry experiences.

Register

Speakers:

Moderator:

Helen Langan

EVP, Medical Affairs Strategy and Transformation

Omnicom Health Medical Communications

Speaker:

Lucy Turner

Medical Lead, GI Cancers and Emerging Portfolio, Europe and Canada

AstraZeneca

Speaker:

Gurinder S. Sidhu

U.S. Antiviral Medical Lead, Senior Director

Pfizer

Speaker:

Alex Schepart, PharmD, MBA

Senior Director, Medical Affairs

Shionogi Inc.

AI As Your Working Partner in Medical Affairs: Rapid Fire Round
2026-01-22 15:00 - 16:00 (America/New_York)

Creativity In Medical Affairs: Proven Principles And Practical Tools
2026-01-30 10:30 - 11:30 (America/New_York)
This webinar explores how Medical Affairs professionals can use a structured approach to creativity to address unmet stakeholder needs across a range of Medical Affairs initiatives.

Specifically, it examines the five principles of Design Thinking—empathy, problem framing, ideation, prototyping, and testing—and how these can be applied to evidence generation, HCP education, treatment pathway optimization, and KOL engagement.

Participants will learn from examples of how Design Thinking has been successfully applied by their peers to meet real-world challenges. They will also come away with practical creativity tools they can begin using immediately to enhance innovation and problem-solving across Medical Affairs workstreams.

Learning Objectives

Apply Design Thinking principles across all Medical Affairs workstreams.

Understand how Medical Affairs professionals have used Design Thinking to address unmet stakeholder needs.

Use practical creativity tools to deliver innovative solutions to Medical Affairs challenges.

Register

Speakers:

Moderator:

Stephen Kagan

Medical Affairs Professional, Professional Development Lead

MAPS

Speaker:

Steve Martino

Managing Partner

M Health

Speaker:

John Surie

Managing Partner

M Health

Speaker:

Simon Morris

Senior Consultant

M Health

Small Team – Big Footprint: Building Global Medical Affairs With Lean Resources
2026-02-06 10:00 - 11:00 (America/New_York)
Due to regulatory uncertainty, difficult patient recruitment, and growing costs, U.S. biotech companies are increasingly looking to Europe to conduct clinical trials and build Medical Affairs functions to prepare for launch.

But how do Medical Affairs departments scale internationally, maintain compliance, and deliver value while managing headcount and resource limitations?

In this session, two Medical Affairs leaders will share case studies illustrating how they built global organizations with lean U.S. teams—offering practical insights for achieving efficiency, maintaining quality, and driving meaningful global impact.

Learning Objectives

Identify common challenges faced when establishing or expanding Medical Affairs organizations globally with limited resources.

Explore the business case for building vs. outsourcing and describe the upskilling needed to achieve impact.

Apply practical strategies for maintaining oversight, quality, responsiveness, and compliance in lean Medical Affairs structures.

Register

Speakers:

Moderator:

Denise Chambley

President, Medical

Amplity

Speaker:

Pam Bacon

Head of Medical Affairs, Europe

Springworks Therapeutics

Speaker:

Brendan Lowe

Human Resources Leader

Crinetics

MAPS Germany Chapter Launch 2026
2026-02-12 10:00 - 16:00 (Europe/Berlin)
Register Now

12 February 2026 • 09:00–16:00 CET • Andaz Munich Schwabinger Tor, Munich

Germany-first working forum

CMD-led, affiliate reality

Take-home outputs

Frameworks + templates

Non-promotional

Scenario-led discussion

Germany-first. CMD-led. Built for execution.

A practical working forum for Germany Medical Affairs leaders focused on three priorities for 2026: GenAI governance, AMNOG/G-BA evidence readiness, and the medical–commercial interface — with take-home tools you can use immediately.

You will leave with:

AI Use-Case Decision Framework (Germany MA) — decision criteria + minimum documentation

AMNOG/G-BA Evidence Readiness Checklist — what to build upstream, before access pressure hits

Minimum viable operating model — decision rights + escalation + documentation for the interface

Format: interactive roundtables + scenario-based clinic (not a lecture series).

Compliance: non-promotional, anonymised scenarios, GDPR-aware.

Agenda

At-a-glance schedule (all times CET). Session facilitators will be confirmed as the programme finalises.

Time (CET)SESSION09:00–10:00Arrival, registration & coffee10:00–10:10Welcome & framing: why this forum / how the day works10:10–10:55CMD Priorities Roundtable – 2026 Execution Priorities for Germany10:55–11:45GenAI Governance in German Medical Affairs – Policy, Risk, and Operating Model11:45–12:05Coffee break12:05–12:50Evidence → Access in Germany: AMNOG / G-BA / HTA readiness12:50–13:50Lunch & peer networking13:50–14:35Medical–Commercial interface in Germany (without crossing lines)14:35–14:55Coffee break14:55–15:40Practical Clinic: Build the tools (“what you’ll use on Monday”)15:40–16:00Closing: priorities, commitments, and post-event outputs

Session outcomes

CMD Priorities Roundtable: Germany MA in 2026

Output: “Top 3 Germany MA priorities for 2026” + “Top 3 operating moves” validated live by the room.

Format: Facilitated roundtable with structured prompts; MAPS captures takeaways for post-event distribution.

Headline Session: GenAI in German Medical Affairs: Germany MA in 2026

Output: AI use-case decision framework for Medical Affairs + minimum viable governance controls and documentation artefacts.

Format: Short framing + moderated discussion focused on operating model, risk, approvals, and implementation.

Evidence → Access in Germany: AMNOG / G-BA / HTA

Output: Evidence readiness checklist (what MA should have ready pre-/post-launch for Germany evidence and access expectations).

Format: Expert-led walkthrough + scenario-based Q&A grounded in Germany affiliate realities.

Medical–Commercial Interface in Germany (Without Crossing Lines)

Output: Clear collaboration model (roles, boundaries, escalation paths) to reduce friction while staying compliant.

Format: Practical scenarios + moderated debate; participants leave with “do / don’t / minimum controls” guidance.

Practical Clinic: Build the Tools

Output: Reusable starter tools (templates/checklists) mapped to the day’s themes: AI governance, evidence readiness, and interface guardrails.

Format: Small-group clinic with report-back; MAPS compiles outputs into a post-event pack.

Register Now

Speakers & CMD Leads

Confirmed presenters and CMD leaders who will facilitate the working sessions.

Sarah Adams

Country Medical Director, Alnylam

Tamas Koncz

President, MAPS EMEA

Tobias Suiter

Germany Country Lead, MAPS

Additional German Medical leaders will be revealed as the programme develops.

Contribute to the Germany Agenda

The Germany Chapter Launch is co-designed with CMDs and senior Medical Affairs leaders. Use the links below to propose a speaker or suggest a priority topic for 2026.

Nominate a Speaker

Suggest a Topic or Case

We are prioritising CMDs and CMD-equivalent leaders working in or closely with affiliates in Germany.

Venue

Andaz Munich Schwabinger Tor

Leopoldstraße 170, 80804 Munich, Germany

A centrally located, modern venue with strong access from Munich Airport and major rail connections. The Andaz provides dedicated space suitable for a CMD-led working session

📍 View on Google Maps

Founding Sponsorship

A limited number of Founding Sponsor opportunities are available for organisations committed to supporting CMD-led Medical Affairs in Germany. Sponsorship is non-promotional, editorially independent, and aligned with MAPS global standards and Germany compliance expectations.

Confirmed sponsors will be displayed here as they are finalised.

Download Sponsorship Prospectus

Contact: dmoore@medicalaffairs.org

Download Sponsorship Prospectus (PDF)

Pricing:

EurosUSDGroup Rate€249 + €199 EUR per additional colleague (up to 5 registrants)$346.80 USD → Your Price: $288.81Maps Member Rate€249 EUR$346.80 USDNon-Member Rate€299 EUR$346.80 USD

Register Now

Related MAPS Resources

Resource: Embracing Omnichannel in Medical Affairs

Resource: Leadership & Management | Change Management

Resource: Value Assessment for Health Technologies

Resource: Scientific & Technical Knowledge | Medical/Commercial Interface

Resource: Compliance Considerations in Medical/Commercial Collaboration

Resource: Advancing Excellence in Medical Affairs

This meeting is not a deep-dive training on these topics, but if you would like additional context, the MAPS resources below align with the themes of the programme.
